Investegate |AstraZeneca PLC Announcements | AstraZeneca PLC: Ultomiris approved in Japan for gMG
Investegate announcements from AstraZeneca PLC, Ultomiris approved in Japan for gMG
Source: investegate.co.uk
Page 7 - Efficacy Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Efficacy Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Efficacy Study Today - Breaking & Trending Today
Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Recardio's Phase 2 Results Will Be Presented as Latebreaker at World Congress on Heart Failure 2022
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction will be presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congre...
Source: pharmiweb.com
Dr. Denise Galloway elected Fellow of the American Association for Cancer Research Academy
Dr. Denise Galloway was elected a member of the American Association for Cancer Research Academy. The Fred Hutchinson Cancer Research Center cancer biologist studies the links between certain viruses and cancer. Her work on HPV helped make the cancer-preventive HPV vaccine possible.
Source: fredhutch.org
Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study
Significance Statement Iron supplementation and erythropoiesis-stimulating agents (ESAs) are curr
Source: asnjournals.org